Hugh Cowley

3.0k total citations · 1 hit paper
11 papers, 2.3k citations indexed

About

Hugh Cowley is a scholar working on Molecular Biology, Pharmacology and Nephrology. According to data from OpenAlex, Hugh Cowley has authored 11 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pharmacology and 2 papers in Nephrology. Recurrent topics in Hugh Cowley's work include Cholinesterase and Neurodegenerative Diseases (3 papers), Phosphodiesterase function and regulation (3 papers) and Vitamin C and Antioxidants Research (2 papers). Hugh Cowley is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (3 papers), Phosphodiesterase function and regulation (3 papers) and Vitamin C and Antioxidants Research (2 papers). Hugh Cowley collaborates with scholars based in United Kingdom and United States. Hugh Cowley's co-authors include Nigel R. Webster, Helen F. Goode, Peter J. Sterk, Anneke Ten Brinke, Peter J. Barnes, Kian Fan Chung, Brian O’Connor, Stephen T. Holgate, Trevor T. Hansel and Anil Mathur and has published in prestigious journals such as The Lancet, Critical Care Medicine and Pharmaceutical Research.

In The Last Decade

Hugh Cowley

11 papers receiving 2.2k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response

2000 1.4k citations Anneke Ten Brinke, Zuzana Diamant et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hugh Cowley United Kingdom	9	1.3k	769	621	422	391	11	2.3k
Ryszard Dworski United States	30	1.9k 1.5×	1.2k 1.5×	531 0.9×	462 1.1×	222 0.6×	52	2.9k
Mohib Uddin Sweden	23	584 0.4×	595 0.8×	973 1.6×	87 0.2×	225 0.6×	39	2.0k
Seoung Ju Park South Korea	29	665 0.5×	620 0.8×	513 0.8×	92 0.2×	185 0.5×	93	2.3k
Theresa W. Gauthier United States	21	386 0.3×	409 0.5×	325 0.5×	88 0.2×	239 0.6×	51	1.6k
Kazuhisa Asai Japan	23	622 0.5×	920 1.2×	264 0.4×	65 0.2×	156 0.4×	120	1.8k
Caifeng Fu United States	9	544 0.4×	328 0.4×	907 1.5×	53 0.1×	210 0.5×	14	4.3k
S. A. Marsico Italy	23	663 0.5×	764 1.0×	243 0.4×	77 0.2×	102 0.3×	46	1.5k
Tatsuo Yamamoto Japan	24	228 0.2×	268 0.3×	229 0.4×	78 0.2×	329 0.8×	82	2.4k
Batya Kristal Israel	27	259 0.2×	158 0.2×	397 0.6×	69 0.2×	199 0.5×	73	1.9k
Johannes Hulthe Sweden	35	408 0.3×	448 0.6×	852 1.4×	68 0.2×	687 1.8×	78	3.3k

Countries citing papers authored by Hugh Cowley

Since Specialization

Citations

This map shows the geographic impact of Hugh Cowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh Cowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh Cowley more than expected).

Fields of papers citing papers by Hugh Cowley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh Cowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh Cowley. The network helps show where Hugh Cowley may publish in the future.

Co-authorship network of co-authors of Hugh Cowley

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh Cowley. A scholar is included among the top collaborators of Hugh Cowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh Cowley. Hugh Cowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Murdoch, R.D., et al.. (2002). Cilomilast (Ariflo®) Does Not Potentiate the Cardiovascular Effects of Inhaled Salbutamol. Pulmonary Pharmacology & Therapeutics. 15(6). 521–527. 8 indexed citations

Port, Andreas, Lisa J. Benincosa, H. Fuder, et al.. (2001). An Overview of the Pharmacokinetics of Cilomilast (Ariflo®), a New, Orally Active Phosphodiesterase 4 Inhibitor, in Healthy Young and Elderly Volunteers. The Journal of Clinical Pharmacology. 41(9). 950–958. 19 indexed citations

Zussman, Barry D., Lisa J. Benincosa, David J. Clark, et al.. (2001). An Overview of the Pharmacokinetics of Cilomilast (Ariflo®), a New, Orally Active Phosphodiesterase 4 Inhibitor, in Healthy Young and Elderly Volunteers. The Journal of Clinical Pharmacology. 41(9). 950–958. 23 indexed citations

Brinke, Anneke Ten, Zuzana Diamant, Brian O’Connor, et al.. (2000). Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response. The Lancet. 356(9248). 2144–2148. 1352 indexed citations breakdown →

Zia‐Amirhosseini, Parnian, Robert Z. Harris, Hugh Cowley, et al.. (2000). Pharmacokinetics of a Hematoregulatory Peptide (SK&F 107647) in Healthy Male Volunteers and in Patients with Colorectal or Pancreatic Adenocarcinoma Not Amenable to Standard Therapy. Pharmaceutical Research. 17(4). 385–390. 2 indexed citations

Cox, Peter J., David Ryan, F. J. Hollis, et al.. (2000). Absorption, Disposition, and Metabolism of Rosiglitazone, a Potent Thiazolidinedione Insulin Sensitizer, in Humans. Drug Metabolism and Disposition. 28(7). 772–780. 176 indexed citations

Martinez, Diana, Osama Mawlawi, Dah‐Ren Hwang, et al.. (2000). Positron emission tomography study of pindolol occupancy of 5-HT1A receptors in humans: preliminary analyses. Nuclear Medicine and Biology. 27(5). 523–527. 20 indexed citations

Zia‐Amirhosseini, Parnian, et al.. (1999). Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in mild asthmatics. Clinical Pharmacology & Therapeutics. 65(2). 147–147. 3 indexed citations

Cowley, Hugh, Pamela Bacon, Helen F. Goode, et al.. (1996). Plasma antioxidant potential in severe sepsis. Critical Care Medicine. 24(7). 1179–1183. 167 indexed citations

10.

Goode, Helen F., Hugh Cowley, B. E. Walker, P D Howdle, & Nigel R. Webster. (1995). Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Critical Care Medicine. 23(4). 646–651. 366 indexed citations

11.

Cowley, Hugh, et al.. (1994). Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome. Critical Care Medicine. 22(4). 651–657. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact